A detailed history of Hbk Sorce Advisory LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 3,726 shares of EXAS stock, worth $210,519. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,726
Holding current value
$210,519
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.43 - $70.83 $158,094 - $263,912
3,726 New
3,726 $253,000
Q2 2023

Aug 04, 2023

SELL
$62.68 - $95.05 $188,478 - $285,815
-3,007 Reduced 50.27%
2,975 $279,000
Q1 2023

Aug 15, 2023

SELL
$47.19 - $70.77 $141 - $212
-3 Reduced 0.1%
2,972 $201,000
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $87,584 - $131,349
-1,856 Reduced 23.68%
5,982 $608,000
Q4 2022

Feb 09, 2023

BUY
$30.35 - $53.15 $237,883 - $416,589
7,838 New
7,838 $388,000
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $162,088 - $232,432
-2,816 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$72.5 - $100.68 $6,017 - $8,356
-83 Reduced 2.86%
2,816 $219,000
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $19,943 - $27,415
-221 Reduced 7.08%
2,899 $277,000
Q2 2021

Aug 12, 2021

BUY
$93.66 - $139.27 $292,219 - $434,522
3,120 New
3,120 $388,000
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $434,100 - $619,358
-4,358 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $21,219 - $29,684
291 Added 7.16%
4,358 $444,000
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $5,575 - $9,275
-100 Reduced 2.4%
4,067 $354,000
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $157,929 - $435,201
4,167 New
4,167 $242,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hbk Sorce Advisory LLC Portfolio

Follow Hbk Sorce Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.